Panel Discussion | Translating GLP-1s, Rezmiteron, FGF21 Therapies into Clinical Practice Guidelines in a Rapidly Changing Landscape
Time: 3:30 pm
day: Conf Day 1 EOD
Details:
- Assessing how emerging therapies fit into the standard of care
- Navigating the future of combination therapies to optimize treatment
- Evaluating how this will play out in the real world with access, non-responders, standard of care and the shift to primary care providers
